Lynch & Associates Johnson & Johnson Transaction History

Lynch & Associates

$467 Million
Q3 2024

A detailed history of Lynch & Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Lynch & Associates holds 90,800 shares of JNJ stock, worth $13.2 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

90,800

Previous 91,451 0.71%

Holding current value

$13.2 Million

Previous $13.4 Million 10.09%

% of portfolio

3.15%

Previous 3.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $94,707 - $108,964	-651 Reduced 0.71%	90,800 $14.7 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $331,063 - $361,789	2,293 Added 2.57%	91,451 $13.4 Million
Q1 2024 Apr 09, 2024	SELL	$155.22 - $162.74 $559,412 - $586,514	-3,604 Reduced 3.89%	89,158 $14.1 Million
Q4 2023 Jan 08, 2024	SELL	$145.6 - $158.88 $161,179 - $175,880	-1,107 Reduced 1.18%	92,762 $14.5 Million
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $82,547 - $92,474	-530 Reduced 0.56%	93,869 $14.6 Million
Q2 2023 Oct 24, 2023	SELL	$154.35 - $166.11 $61,122 - $65,779	-396 Reduced 0.42%	94,399 $15.6 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $60,813 - $65,447	-394 Reduced 0.42%	94,399 $15.6 Million
Q1 2023 Oct 24, 2023	BUY	$151.05 - $180.26 $59,815 - $71,382	396 Added 0.42%	94,795 $14.7 Million
Q1 2023 Apr 04, 2023	SELL	$151.05 - $180.26 $199,537 - $238,123	-1,321 Reduced 1.37%	94,793 $14.7 Million
Q4 2022 Oct 24, 2023	BUY	$160.2 - $179.79 $359,809 - $403,808	2,246 Added 2.39%	96,115 $17 Million
Q4 2022 Jan 05, 2023	SELL	$160.2 - $179.79 $90,993 - $102,120	-568 Reduced 0.59%	96,114 $17 Million
Q3 2022 Oct 03, 2022	SELL	$161.33 - $179.52 $229,895 - $255,816	-1,425 Reduced 1.45%	96,682 $15.8 Million
Q2 2022 Jul 06, 2022	SELL	$168.19 - $186.01 $11,773 - $13,020	-70 Reduced 0.07%	98,107 $17.4 Million
Q1 2022 Apr 08, 2022	BUY	$158.14 - $179.59 $86,186 - $97,876	545 Added 0.56%	98,177 $17.4 Million
Q4 2021 Jan 11, 2022	BUY	$155.93 - $173.01 $255,725 - $283,736	1,640 Added 1.71%	97,632 $16.7 Million
Q3 2021 Oct 12, 2021	SELL	$161.5 - $179.47 $2,099 - $2,333	-13 Reduced 0.01%	95,992 $15.5 Million
Q2 2021 Jul 21, 2021	SELL	$159.48 - $171.07 $115,941 - $124,367	-727 Reduced 0.75%	96,005 $15.8 Million
Q1 2021 Apr 09, 2021	BUY	$153.07 - $170.48 $184,755 - $205,769	1,207 Added 1.26%	96,732 $15.9 Million
Q4 2020 Jan 20, 2021	BUY	$137.11 - $157.38 $183,453 - $210,574	1,338 Added 1.42%	95,525 $15 Million
Q3 2020 Oct 21, 2020	SELL	$140.38 - $153.83 $169,017 - $185,211	-1,204 Reduced 1.26%	94,187 $14 Million
Q2 2020 Jul 20, 2020	SELL	$128.81 - $155.51 $306,310 - $369,802	-2,378 Reduced 2.43%	95,391 $13.4 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $51,124 - $70,835	-460 Reduced 0.47%	97,769 $12.8 Million
Q4 2019 Jan 10, 2020	BUY	$127.5 - $146.44 $26,137 - $30,020	205 Added 0.21%	98,229 $14.3 Million
Q3 2019 Oct 03, 2019	SELL	$126.95 - $142.14 $38,719 - $43,352	-305 Reduced 0.31%	98,024 $12.7 Million
Q2 2019 Jul 19, 2019	SELL	$131.15 - $144.24 $64,263 - $70,677	-490 Reduced 0.5%	98,329 $13.7 Million
Q1 2019 Apr 25, 2019	BUY	$125.72 - $139.79 $210,455 - $234,008	1,674 Added 1.72%	98,819 $13.8 Million
Q4 2018 Jan 10, 2019	BUY	$122.84 - $147.84 $202,440 - $243,640	1,648 Added 1.73%	97,145 $12.5 Million
Q3 2018 Oct 05, 2018	BUY	$121.58 - $142.88 $442,672 - $520,226	3,641 Added 3.96%	95,497 $13.2 Million
Q2 2018 Jul 09, 2018	SELL	$119.4 - $131.76 $25,312 - $27,933	-212 Reduced 0.23%	91,856 $11.1 Million
Q1 2018 Apr 06, 2018	SELL	$125.1 - $148.14 $276,471 - $327,389	-2,210 Reduced 2.34%	92,068 $11.8 Million
Q4 2017 Jan 04, 2018	BUY	$131.22 - $143.62 $40,940 - $44,809	312 Added 0.33%	94,278 $13.2 Million
Q3 2017 Oct 18, 2017	BUY	$129.47 - $135.38 $12.2 Million - $12.7 Million	93,966	93,966 $12.2 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Account

Lynch & Associates Johnson & Johnson Transaction History